immune globulin
Showing 1 - 25 of >10,000
Survey of Human Rabies Immune Globulin Safety in Children
Recruiting
- Rabies
- +3 more
- Human rabies immune globulin 300 IU/mL
-
Houston, TexasHouston Methodist
Aug 22, 2022
Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))
Withdrawn
- Chronic Hepatitis B
- hepatitis B immune globulin (HBIg)
- Pegylated interferon alfa (pegIFN)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 4, 2022
Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- HYQVIA
- (no location specified)
Feb 23, 2023
Primary Immunodeficiency Diseases (PID) Trial in Japan (Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20%
Completed
- Primary Immunodeficiency Diseases (PID)
- Immune Globulin Intravenous (IGIV)
- Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
-
Nagoya-shi, Aichi, Japan
- +7 more
Feb 23, 2022
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune
Recruiting
- CIDP
- +2 more
- Intravenous immune globulin G
- Subcutaneous immune globulin G
-
New Brunswick, New JerseyRutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022
Hepatitis A Trial in Almaty (Hepatitis A vaccine)
Completed
- Hepatitis A
- Hepatitis A vaccine
-
Almaty, KazakhstanSanitary EpidemiologyAuthority
Dec 27, 2021
Obesity, Immune Deficiency Trial in Somerville (Institutional standard intravenous immune globulin treatment)
Recruiting
- Obesity
- Immune Deficiency
- Institutional standard intravenous immune globulin treatment
-
Somerville, New JerseyRobert Wood Johnson University Hospital Somerset
Oct 10, 2022
Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))
Withdrawn
- Healthy
- Communicable Diseases
- Vaccinia Immune Globulin (Human)
- (no location specified)
Oct 28, 2021
Primary Immunodeficiency Diseases (PID) Trial (TAK-881)
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- TAK-881
- (no location specified)
Oct 4, 2023
Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)
Recruiting
- Lung Transplant
- Hepatitis B
- Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
-
Philadelphia, PennsylvaniaHospital of University of Pennsylvania
Oct 1, 2022
Sickle Cell Disease, Pain Trial in Bronx (Immune Globulin Intravenous, Normal saline)
Recruiting
- Sickle Cell Disease
- Pain
- Immune Globulin Intravenous
- Normal saline
-
Bronx, New YorkMontefiore Medical Center
Jul 25, 2022
COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)
Not yet recruiting
- COPD Exacerbation Acute
- CUVITRU - Ig subcutaneous human 20%
- Standard Medical Therapy
-
Rochester, New York
- +2 more
Feb 28, 2023
Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome Trial in Amsterdam (Immune Globulin Intravenous
Recruiting
- Inflammatory Myopathy, Idiopathic
- +5 more
- Immune Globulin Intravenous (Human)
- Placebo
-
Amsterdam, North- Holland, NetherlandsDepartment of Neurology, Amsterdam UMC, location AMC
Apr 14, 2023
Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)
Completed
- Immunologic Deficiency Syndromes
- GC5107
-
Centennial, Colorado
- +19 more
Nov 11, 2022
Healthy Volunteers Trial in Hialeah (TAK-881)
Completed
- Healthy Volunteers
- TAK-881
-
Hialeah, FloridaClinical Pharmacology of Miami
Apr 28, 2022
Primary Immune Deficiency Disorder Trial in United States (Bivigam, Other)
Active, not recruiting
- Primary Immune Deficiency Disorder
- Bivigam
- Other
-
Carpinteria, California
- +16 more
Jan 30, 2023
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Lymphoma Trial in Seattle (biological, other, procedure)
Not yet recruiting
- Lymphoma
- Immune Globulin Infusion (Human), 10% Solution
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 21, 2023
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Rabies Trial in Philippines, United States (SYN023, HRIG (HyperRab), Rabies vaccine)
Completed
- Rabies
- SYN023
- +2 more
-
Gainesville, Florida
- +13 more
Sep 29, 2022
Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver Transplantation Trial in Phoenix, Jacksonville,
Terminated
- Sequelae of Viral Hepatitis
- +2 more
- Hepatitis C Immune Globulin Intravenous (Human) 5%
-
Phoenix, Arizona
- +2 more
Jul 28, 2021
Primary Immunodeficiency Trial in United States (Immune Globulin Intravenous, Prometic's Immune Globulin Intravenous 10%)
Completed
- Primary Immunodeficiency
- Immune Globulin Intravenous
- Prometic's Immune Globulin Intravenous 10%
-
Irvine, California
- +12 more
Nov 3, 2021
Primary Immunodeficiency Diseases (PID), Agammaglobulinemia, Hypogammaglobulinemia Trial in Finland, Sweden (Immune Globulin
Completed
- Primary Immunodeficiency Diseases (PID)
- +2 more
- Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution
- Gammagard S/D (Solvent/Detergent)
-
Tampere, Finland
- +5 more
Aug 22, 2021